Menu

Home
Patients & Public
Centres
News & Resources
Unblinding
- Unblinding for Republic of Ireland
- Unblinding for India
Trainee Scheme
Member Resources
- India Resources
- Republic of Ireland Resources

Search the site

Sitemap
Members Area
- Login

News

Add-Aspirin cancer trial completes recruitment after a decade of work

Posted by News Author on 28 May 2025

Cancer

2025
- May
- March
2022
2021
2020
2019
2018
2017
2016
2015

Categories

Cancer
Documents
General
Events

News and Resources

News
Presentations, Posters & Abstracts
Publications

The trial is being jointly funded by Cancer Research UK (grant number C471 /A15015), the National Institute for Health Research Health Technology Assessment Programme (project number 12/01/38) and the MRC Clinical Trials Unit at UCL. In India, the Sir Dorabji Tata Trust provides funding.

Quick links

Register Participant
Unblind a participant
Contact Us

Social pages

twitter
rss

© 2025 Add-Aspirin, MRC CTU at UCL
Sitemap
RSS
Cookies
Page last updated: 14-Oct-2021 13:15